YGoY

Symptoms of Guillain-Barre Syndrome

Symptoms of Guillain-Barre syndrome make the affected person become very fragile by the second week of their onset. By the third week, 90 percent affected people find themselves at the weakest state of their life.

There are no cause and cure for this rare and severe form of autoimmune condition affecting the nerves which connect the central nervous system of the body with all the limbs and organs. It is one of the leading causes of paralysis belonging to non-traumatic origin.

Symptoms of Guillain-Barre Syndrome:

  • Arm weakness
  • Leg weakness
  • Upper body weakness
  • Arm tingling
  • Leg tingling
  • Upper body tingling
  • Progressive muscle weakness existing for hours to 3-4 weeks
  • Facial paralysis
  • Loss of reflexes
  • Changes in blood pressure
  • Muscle tenderness
  • Stiffness
  • Back pain
  • Fever
  • Trunk weakness
  • Pins and needles sensation
  • Neck weakness
  • Dysautonomia – Malfunction of the nervous system
  • Arrhythmias – Abnormal heart rhythms
  • Decreased consciousness

Symptoms of Guillian-Barre syndrome are similar to the signs of the condition progressive inflammatory neuropathy. Cerebrospinal fluid analysis and electrodiagnostic tests of nerves and muscles are couple of tests which form the part of diagnosis of this condition.

Facts and Statistics on Guillian-Barre Syndrome:

  • Muscle weakness and tingling sensations are experienced by nearly three percent patients even years after the first attack.
  • Residual weakness in found in 30 percent patients after three years of the condition’s onset.
  • Plasmapheresis and high-dose immunoglobulin therapy are used to address the condition.
  • The condition is a syndrome and not a disease as no agent responsible for causing the ailment is known yet.
  • The former reduces the severity and duration of this syndrome. The later reduces the attack of the immune system on the nervous system.
  • According to the National Institute of Neurological Disorders and Stroke, neurological scientists, immunologists, virologists, and pharmacologists are working together to develop an effective treatment method for this condition.

Leave a reply

Your email address will not be published. Required fields are marked *